Niagen Bioscience, Inc. (NASDAQ: NAGE) has officially introduced Tru Niagen® Skincare, establishing a permanent category within its core product line. This launch includes the Niagen NanoCloud™, a dermatologically tested topical product that utilizes patented nicotinamide riboside (NR), a specific form of vitamin B3, also featured in Tru Niagen® supplements.
Read More
The Niagen NanoCloud™ is delivered in a unique waterless, precision-dosed sachet that activates in under 10 seconds when combined with any water-based serum or moisturizer. The product aims to enhance skin's youthful appearance, improve texture, and boost hydration without necessitating the replacement of existing skincare products. It can be found on the company’s website, www.truniagen.com, in new packaging.
Rob Fried, CEO of Niagen Bioscience, highlighted the company's expansion into skincare, stating that the positive consumer feedback from NanoCloud's initial limited release prompted its inclusion as a core offering.
According to Fortune Business Insights, the global skincare industry was valued at approximately $122.11 billion in 2025, with projections to reach $227.13 billion by 2034. The anti-aging cosmetics sector alone is estimated to grow from $63.71 billion in 2026 to $106.98 billion by 2035, as reported by Precedence Research. Moreover, Grand View Research indicates that the U.S. NAD+ products market will see a compound annual growth rate of 12.2% from 2025 to 2033, with topical products expected to be the fastest-growing segment.
The introduction of NanoCloud is a testament to Niagen Bioscience's commitment to address key challenges in NAD+ skincare, as traditional water-based NAD+ products tend to degrade rapidly. Initially launched as a limited release in March 2026, the response from users has led to its selection as a permanent part of the Tru Niagen lineup.